Amrize (NYSE:AMRZ) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Amrize (NYSE:AMRZFree Report) from a sell rating to a hold rating in a research note issued to investors on Sunday morning.

A number of other research firms also recently commented on AMRZ. Oppenheimer restated an “outperform” rating and issued a $70.00 price objective (up from $64.00) on shares of Amrize in a report on Thursday, February 19th. Royal Bank Of Canada raised their price target on shares of Amrize from $60.00 to $61.00 and gave the company a “sector perform” rating in a report on Thursday, February 19th. Citigroup boosted their price objective on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Bank of America set a $58.00 price objective on shares of Amrize in a research report on Monday, January 12th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $70.00 target price on shares of Amrize in a report on Thursday, December 18th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $63.43.

Get Our Latest Stock Report on AMRZ

Amrize Stock Performance

NYSE:AMRZ opened at $61.70 on Friday. The company has a market cap of $34.13 billion and a P/E ratio of 25.08. The firm’s 50 day moving average is $57.33 and its two-hundred day moving average is $53.24. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The business’s revenue for the quarter was down .4% on a year-over-year basis.

Insiders Place Their Bets

In other news, CFO Ian A. Johnston purchased 1,200 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were purchased at an average price of $63.92 per share, with a total value of $76,704.00. Following the purchase, the chief financial officer directly owned 18,544 shares of the company’s stock, valued at approximately $1,185,332.48. This represents a 6.92% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Institutional Trading of Amrize

Large investors have recently modified their holdings of the business. MCF Advisors LLC purchased a new position in Amrize in the fourth quarter valued at about $27,000. Basepoint Wealth LLC purchased a new stake in Amrize during the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC acquired a new position in shares of Amrize in the 4th quarter valued at approximately $34,000. State of Wyoming purchased a new position in shares of Amrize during the 3rd quarter valued at approximately $32,000. Finally, Itau Unibanco Holding S.A. grew its position in shares of Amrize by 150.0% during the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after buying an additional 450 shares in the last quarter.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

See Also

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.